Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Alabama at Birmingham
Global Coalition for Adaptive Research
NRG Oncology
Mayo Clinic
University of California, San Francisco
NRG Oncology
Case Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Sapience Therapeutics
Mayo Clinic
BPGbio
NRG Oncology
M.D. Anderson Cancer Center
Northwestern University
National Institutes of Health Clinical Center (CC)
Northwestern University
Karolinska Institutet
Hopital Foch
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Northwestern University
M.D. Anderson Cancer Center
Thomas Jefferson University